Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Trulieve Cannabis (TCNNF) Inventory (2020 - 2026)

Trulieve Cannabis has reported Inventory over the past 6 years, most recently at $242.3 million for Q4 2025.

  • For Q4 2025, Inventory rose 4.72% year-over-year to $242.3 million; the TTM value through Dec 2025 reached $242.3 million, up 4.72%, while the annual FY2025 figure was $242.3 million, 4.72% up from the prior year.
  • Inventory for Q4 2025 was $242.3 million at Trulieve Cannabis, roughly flat from $243.3 million in the prior quarter.
  • Over five years, Inventory peaked at $301.2 million in Q3 2022 and troughed at $103.9 million in Q1 2021.
  • A 5-year average of $223.8 million and a median of $233.9 million in 2022 define the central range for Inventory.
  • Biggest five-year swings in Inventory: surged 139.91% in 2022 and later fell 29.63% in 2024.
  • Year by year, Inventory stood at $212.2 million in 2021, then skyrocketed by 30.31% to $276.5 million in 2022, then fell by 22.92% to $213.1 million in 2023, then increased by 8.56% to $231.4 million in 2024, then rose by 4.72% to $242.3 million in 2025.
  • Business Quant data shows Inventory for TCNNF at $242.3 million in Q4 2025, $243.3 million in Q3 2025, and $241.5 million in Q2 2025.